Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John McCoy

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Cosmetic Dermatology|May 31, 2021
Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional studyYanrui Gao, Yingfang Li, Yimei Tan, et al.
Medical Hypotheses|December 14, 2020
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine boosterAndy Goren, Flavio Adsuara Cadegiani, Carlos Gustavo Wambier, et al.
Journal of Cosmetic Dermatology|April 18, 2020
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severityAndy Goren, Sergio Vaño-Galván, Carlos Gustavo Wambier, et al.
Frontiers in Medicine|August 5, 2021
Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled TrialJohn McCoy, Andy Goren, Flávio Adsuara Cadegiani, et al.
Journal of the American Academy of Dermatology|May 25, 2020
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign"Carlos Gustavo Wambier, Sergio Vaño-Galván, John McCoy, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Cosmetic Dermatology|May 31, 2021
Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional studyYanrui Gao, Yingfang Li, Yimei Tan, et al.
Medical Hypotheses|December 14, 2020
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine boosterAndy Goren, Flavio Adsuara Cadegiani, Carlos Gustavo Wambier, et al.
Journal of Cosmetic Dermatology|April 18, 2020
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severityAndy Goren, Sergio Vaño-Galván, Carlos Gustavo Wambier, et al.
Frontiers in Medicine|August 5, 2021
Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled TrialJohn McCoy, Andy Goren, Flávio Adsuara Cadegiani, et al.
Journal of the American Academy of Dermatology|May 25, 2020
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign"Carlos Gustavo Wambier, Sergio Vaño-Galván, John McCoy, et al.
Pageof 5